ANTX vs APM

AN2 Therapeutics, Inc. vs Aptorum Group Limited — Valuation Comparison 2026

ANTX

Biotechnology
AN2 Therapeutics, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$4.46
Last close
Models
7/13
Active
VS

APM

Biotechnology
Aptorum Group Limited
Quality
2.2
out of 10
Value Trap
Price
$0.84
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType ANTX Fair ValueANTX Upside APM Fair ValueAPM Upside
Bayesian DCF Intrinsic $2.01 -55.0% $0.22 -73.6%
Earnings Power Value Intrinsic $0.06 -92.8%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.38 -91.4% $0.35 -58.1%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ANTX vs APM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ANTX vs APM — Which Stock Is More Undervalued?

ANTX scores higher with a 4.3/10 quality rating vs APM's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing AN2 Therapeutics, Inc. (ANTX) and Aptorum Group Limited (APM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ANTX currently trades at $4.46 with a QOC of 4.3/10, while APM trades at $0.84 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).